Invitae Corporation Invitae Corporation

Invitae Corporation

NVTA

Kedudukan dalam Saham #35781
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Harga Saham
$0.016
Disegerakkan terakhir: 2024-03-11
Modal Pasaran
$3.27M
Perubahan (1 hari)
-5.33%
Perubahan (1 tahun)
5,233.33%
Negara
US
Perdagangan Invitae Corporation (NVTA)

Kategori

Healthcare
Bilangan saham terbitan bagi Invitae Corporation (NVTA)
Bilangan saham terbitan setakat September 2023: 275.60M
Menurut laporan kewangan terkini dan harga saham Invitae Corporation, bilangan saham terbitan semasa ialah 275.60M. Pada akhir December 2022, syarikat mempunyai 235.68M saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Invitae Corporation (NVTA) dari 2016 hingga 2026
Saham terbitan pada akhir setiap tahun
Tahun Saham Terbitan Ubah
2026 (TTM) 275.60M 0.00%
2023 275.60M 16.94%
2022 235.68M 11.72%
2021 210.95M 56.74%
2020 134.59M 48.13%
2019 90.86M 36.12%
2018 66.75M 43.51%
2017 46.51M 40.20%
2016 33.18M 0.00%
Saham terbitan bagi syarikat atau pesaing yang serupa
Syarikat Saham Terbitan Perbezaan Negara
371.00M 34.61%
US
705.30M 155.91%
US
143.28M -48.01%
US
- -
CN
282.00M 2.32%
US